Skip to main content

Table 1 Impact on TB incidence and mortality, by country and for the whole region, by 2030 relative to 2015. Estimates show the incremental impact attributable to preventive therapy alone, in the context of each comparator. Thus estimates under the ‘status quo’ comparator reflect the difference between the blue and orange curves in the left-hand panel of Fig. 2 and estimates under the ‘improved TB cascade’ comparator reflect the difference between the green and yellow curves in the right-hand panel of Fig. 2

From: The potential impact of preventive therapy against tuberculosis in the WHO South-East Asian Region: a modelling approach

 Incremental impact of preventive therapy relative to ‘Status quo comparator’Incremental impact of preventive therapy relative to ‘improved TB cascade’ comparator
% reduction in annual incidence rate (2030 relative to 2015)% reduction in annual TB deaths (2030 relative to 2015)% reduction in annual incidence rate (2030 relative to 2015)% reduction in annual TB deaths (2030 relative to 2015)
Bangladesh4.84 [4.33–8.14]3.70 [1.62–7.79]4.45 [3.79–5.60]1.70 [0.57–4.21]
Bhutan3.23 [2.76–6.58]3.02 [0.99–7.79]5.25 [2.66–4.25]1.67 [0.43–4.63]
DPR Korea15.90 [4.94–30.42]15.60 [3.87–40.46]8.79[−2.01–14.89]4.80[− 1.08–14.94]
India6.94 [5.04–10.64]6.69 [4.56–9.47]6.44 [5.08–8.33]3.59 [2.48–6.07]
Indonesia9.79 [7.23–14.13]6.61 [4.83–8.50]7.81 [6.52–10.05]3.19 [2.41–4.60]
Maldives3.45 [1.90–16.50]0.14 [0.10–0.44]1.97 [1.45–2.89]0.07 [0.06–0.09]
Myanmar10.59 [8.07–23.98]8.25 [4.40–18.63]12.41 [9.02–23.00]6.02 [2.81–11.26]
Nepal6.17 [4.56–13.68]8.80 [3.34–23.87]5.22 [4.12–7.78]4.71 [1.17–13.02]
Sri Lanka2.01 [1.58–3.00]1.27 [0.64–3.39]2.15 [1.68–2.83]1.06 [0.38–2.29]
Thailand13.94 [7.96–36.96]7.25 [3.17–19.43]9.06 [6.47–15.52]3.03 [1.23–7.89]
Timor Leste49.4 [28.74–84.77]39.18 [16.70–92.83]22.39 [12.56–40.23]9.47 [2.75–30.10]
SEAR8.30 [6.48–10.83]6.75 [5.19–8.54]6.93 [5.81–8.51]3.52 [2.72–5.08]